NASDAQ:IPAR - Nasdaq - US4583341098 - Common Stock - Currency: USD
We assign a fundamental rating of 6 out of 10 to IPAR. IPAR was compared to 35 industry peers in the Personal Care Products industry. Both the health and profitability get an excellent rating, making IPAR a very profitable company, without any liquidiy or solvency issues. IPAR is not valued too expensively and it also shows a decent growth rate. These ratings could make IPAR a good candidate for quality investing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 11.51% | ||
ROE | 21.02% | ||
ROIC | 18.91% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 19.49% | ||
PM (TTM) | 11.3% | ||
GM | 56.04% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.15 | ||
Debt/FCF | 0.85 | ||
Altman-Z | 6.82 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.97 | ||
Quick Ratio | 1.68 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 25.94 | ||
Fwd PE | 22.95 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 23.44 | ||
EV/EBITDA | 13.12 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 2.41% |
NASDAQ:IPAR (7/1/2025, 12:36:46 PM)
136.705
+5.4 (+4.11%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 2.41% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 25.94 | ||
Fwd PE | 22.95 | ||
P/S | 2.99 | ||
P/FCF | 23.44 | ||
P/OCF | 18.91 | ||
P/B | 5.57 | ||
P/tB | 9.22 | ||
EV/EBITDA | 13.12 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 11.51% | ||
ROE | 21.02% | ||
ROCE | 25.21% | ||
ROIC | 18.91% | ||
ROICexc | 22.26% | ||
ROICexgc | 32.84% | ||
OM | 19.49% | ||
PM (TTM) | 11.3% | ||
GM | 56.04% | ||
FCFM | 12.77% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.15 | ||
Debt/FCF | 0.85 | ||
Debt/EBITDA | 0.37 | ||
Cap/Depr | 158.92% | ||
Cap/Sales | 3.06% | ||
Interest Coverage | 36.8 | ||
Cash Conversion | 73.92% | ||
Profit Quality | 112.98% | ||
Current Ratio | 2.97 | ||
Quick Ratio | 1.68 | ||
Altman-Z | 6.82 |